BrainCool AB

BRAIN · Nasdaq Stockholm · Healthcare

1.10SEK +0.4%last day

Price as of 2 October 2026

The price over the past year, with dividends: +16.6%

Performance

1 month

+21.9%

1 year

+16.6%

3 years, per year

−39.6%

5 years, per year

−29.3%

Largest fall, 3 years

−92.4%

Below the peak now

−93.2%

Volatility, 1 year

64.3%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.6

Dividend yield

0.0%

Return on equity

−21.6%

Net margin

−84.7%

Market value

43 m USD

Quality, value and trend

Where BrainCool stands against every Nordic stock today. 100 is best.

Quality54

Profitability and a sound balance sheet over time. Better than 54% of Nordic stocks.

Value12

The price measured against earnings, assets and cash flow. Better than 12% of Nordic stocks.

Trend87

The price development over the past year. Better than 87% of Nordic stocks.

Combined48

Quality, value and trend together. Better than 48% of Nordic stocks.

About BrainCool

BrainCool AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 15 employees.

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis